trending Market Intelligence /marketintelligence/en/news-insights/trending/Qs5b6aT5G-RWdXf-vCGHfQ2 content esgSubNav
In This List

Aevi Genomic attracts $28M investment

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Aevi Genomic attracts $28M investment

Aevi Genomic Medicine Inc. will sell $28 million in shares to a number of investors, including the Children's Hospital of Philadelphia Foundation, which is leading the offering.

The company will issue 22,222,222 shares at $1.26 apiece, complete with warrants to purchase up to an additional 3,953,904 stocks.

The Children's Hospital of Philadelphia has also committed up to a further $5 million in equity financing until June 30, 2018.

Aevi Genomic will use the net proceeds for the development of its two lead clinical programs along with other product candidates, support its collaboration with Children's Hospital of Philadelphia and for general corporate purposes.

Closing is expected to occur in the fourth quarter.

Jefferies LLC is advising Aevi Genomic on the transaction, with Evercore LLC advising the Children's Hospital of Philadelphia.